<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml">
   <article xmlns="" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
      <head>
         <style type="text/css"> 		 
            	    table {background : #ffffdd;}
            		 	tr {background : #ddddff; padding : 1px;}
            			
         </style>
         <span class="citation_publisher">Hindawi Publishing Corporation</span>
         <h2 class="citation-title">A Role for Notch Signalling in Breast Cancer and Endocrine Resistance</h2>
         <span class="doi">10.1155/2016/2498764</span>
         <div class="contrib-group">contrib: 
            	  CONT
            	  
            <span class="citation_author">Ahmet Acar</span>
            <span class="citation_author_institution_ref">1</span>
            <span class="citation_author">Bruno M. Simões</span>
            <span class="citation_author_institution_ref">2</span>
            <span class="citation_author">Robert B. Clarke</span>
            <span class="citation_author_institution_ref">2</span>
            <span class="citation_author">Keith Brennan</span>
            <span class="citation_author_institution_ref">1</span>
         </div>
         <span class="email">[keith.brennan@manchester.ac.uk]</span>
         <span class="conflict">[]</span>
         <span class="contribs">[]</span>
         <span class="citation_pubdate">[2016-1-10]</span>
         <span class="citation_copyright">[Copyright 2016: ]</span>
         <span class="citation_licence">[Licence This is an open access article distributed under the Creative Commons Attribution
            License, which permits unrestricted use, distribution, and reproduction in any medium,
            provided the original work is properly cited.]
         </span>
         <span class="citation_funding">[]</span>
         <span class="citation_pagecount">[]</span>
         <span class="citation_data">[]</span>
      </head>
      <div id="abstract" tag="abstract">
         <h2>Abstract</h2>
         <p>Over the past decade, there has been growing interest in the Notch signalling pathway
            within the breast cancer field. This interest stemmed initially from the observation
            that Notch signalling is aberrantly activated in breast cancer and its effects on
            various cellular processes including proliferation, apoptosis, and cancer stem cell
            activity. However more recently, elevated Notch signalling has been correlated with
            therapy resistance in oestrogen receptor-positive breast cancer. As a result, inhibiting
            Notch signalling with therapeutic agents is being explored as a promising treatment
            option for breast cancer patients.
         </p>
      </div>
      <div tagxxx="sec">
         <title>1. The Notch Signalling Pathway</title>
         <p>The Notch signalling pathway is evolutionarily conserved and is found in organisms
            as diverse as hydra and humans. In mammals, there are four Notch receptors (Notch1
            to Notch4) and five DSL ligands (Jagged1, Jagged2, Delta-like1 (Dll1), Dll3, and Dll4)
            [
            <span ref-type="bibr" rid="B43">
               <sup>
                  <a href="#B43">1</a>
               </sup>
            </span>]. As the DSL ligands are transmembrane proteins, Notch signalling is initiated by
            the interaction of DSL ligands and Notch receptors on adjacent cells. Their interaction
            leads to a proteolytic cleavage of the Notch protein at the S2 cleavage site mediated
            by ADAM10 and ADAM17. Following this cleavage, the remaining part of the Notch protein
            undergoes another proteolytic cleavage mediated by the 
            <i>γ</i>-secretase enzyme complex. The latter cleavage releases the Notch intracellular domain
            (NICD), which translocates to the nucleus. Within the nucleus, NICD forms a complex
            with the DNA binding protein RBPj and a member of the Mastermind-like (MAML) family
            transcriptional coactivators (
            <span ref-type="fig" rid="fig1">Figure 1</span>). This complex of proteins then activates the transcription of Notch target genes,
            including members of
            <i> Hes</i> and
            <i> Hey</i> family of transcription. Other target genes include several genes that are directly
            associated with tumourigenesis such as
            <i> cyclinD1</i> and
            <i> Slug</i> [
            <span ref-type="bibr" rid="B4">
               <sup>
                  <a href="#B4">2</a>
               </sup>
            </span>, 
            <span ref-type="bibr" rid="B27">
               <sup>
                  <a href="#B27">3</a>
               </sup>
            </span>]. Notch signalling activity is also regulated through posttranslational modification.
            For example, Notch receptors are glycosylated through the sequential action of peptide-O-fucosyltransferase
            (POFUT1) [
            <span ref-type="bibr" rid="B50">
               <sup>
                  <a href="#B50">4</a>
               </sup>
            </span>] and the Fringe GlcNAc transferases [
            <span ref-type="bibr" rid="B37">
               <sup>
                  <a href="#B37">5</a>
               </sup>
            </span>]; this modification alters the affinity of Notch for Delta and Serrate/Jagged ligands.
            Notch proteins are also subject to phosphorylation by glycogen synthase kinase 3
            <i>β</i> (GSK3
            <i>β</i>) [
            <span ref-type="bibr" rid="B12">
               <sup>
                  <a href="#B12">6</a>
               </sup>
            </span>] and ubiquitination by the E3 ubiquitin ligase FBXW7 [
            <span ref-type="bibr" rid="B26">
               <sup>
                  <a href="#B26">7</a>
               </sup>
            </span>]. These latter modifications alter the stability of NICD and thereby control the
            duration of signalling.
         </p>
      </div>
      <div tagxxx="sec">
         <title>2. Notch Signalling Is Aberrantly Activated in Breast Cancer</title>
         <p>Breast cancer is one of the leading causes of death seen in the world despite the
            fact that there are ongoing efforts to improve detection and treatment. Breast cancer
            is a heterogeneous disease and currently is split into three subtypes clinically based
            on immunohistochemical analysis: ER
            <i>α</i> +ve (oestrogen receptor 
            <i>α</i>-positive), HER2 +ve (human epidermal growth factor receptor 2-positive), and triple
            negative (cancers that lack expression of ER
            <i>α</i>, progesterone receptor (PR), and HER2). Currently, targeted therapies are available
            for ER
            <i>α</i> and Her2 +ve tumours. In addition to traditional subtype analysis, breast cancer
            can also be subtyped based on gene expression profiles. Perou and colleagues reported
            the presence of luminal-like, normal-like, basal-like, and Her2-enriched subtypes
            [
            <span ref-type="bibr" rid="B40">
               <sup>
                  <a href="#B40">8</a>
               </sup>
            </span>]. They also split the luminal-like subtype into luminal A and luminal B subtypes.
            Although not perfectly aligned, the luminal-like, Her2-enriched, and basal-like subtypes
            correlate with ER
            <i>α</i> +ve, HER2 +ve, and triple negative breast cancer subtypes identified by immunohistochemistry.
            More recently a sixth molecular subtype has been recognised, the claudin-low subtype
            [
            <span ref-type="bibr" rid="B21">
               <sup>
                  <a href="#B21">9</a>
               </sup>
            </span>]. Alternative molecular subtypes that link to copy number aberration data have also
            been proposed [
            <span ref-type="bibr" rid="B7">
               <sup>
                  <a href="#B7">10</a>
               </sup>
            </span>].
         </p>
         <p>Over the past decade, aberrant activation of Notch signalling in breast cancer has
            been reported by many different groups. In invasive breast cancer, the elevated expression
            of Notch signalling pathway components has been reported, including Jagged1-2, Dll1,
            Dll3, and Dll4, Notch receptors, and
            <i> Hes</i> and
            <i> Hey</i> target genes [
            <span ref-type="bibr" rid="B35">
               <sup>
                  <a href="#B35">11</a>
               </sup>
            </span>]. For example, elevated expression of Jagged1 and Notch1 has been linked to poor
            prognosis in breast cancer patients [
            <span ref-type="bibr" rid="B44">
               <sup>
                  <a href="#B44">12</a>
               </sup>
            </span>–
            <span ref-type="bibr" rid="B8">
               <sup>
                  <a href="#B8">14</a>
               </sup>
            </span>]. Likewise, Numb, a negative regulator of Notch signalling, has been found to be
            lost in 50% of breast cancer through ubiquitination and proteasomal degradation [
            <span ref-type="bibr" rid="B39">
               <sup>
                  <a href="#B39">15</a>
               </sup>
            </span>]. The accumulation of NICD has also been reported [
            <span ref-type="bibr" rid="B54">
               <sup>
                  <a href="#B54">16</a>
               </sup>
            </span>].
         </p>
         <p>There are various examples of elevated Notch signalling being associated with a particular
            subtype of breast cancer and response to targeted therapy. For example, Notch signalling
            has been shown to be activated in ER
            <i>α</i> +ve breast cancer in response to treatment [
            <span ref-type="bibr" rid="B46">
               <sup>
                  <a href="#B46">17</a>
               </sup>
            </span>, 
            <span ref-type="bibr" rid="B20">
               <sup>
                  <a href="#B20">18</a>
               </sup>
            </span>]. Elevated Notch1 expression is also found in HER2 +ve [
            <span ref-type="bibr" rid="B59">
               <sup>
                  <a href="#B59">19</a>
               </sup>
            </span>] and triple negative/basal breast tumours [
            <span ref-type="bibr" rid="B45">
               <sup>
                  <a href="#B45">13</a>
               </sup>
            </span>]. In contrast, elevated Notch2 is associated with highly differentiated and poorly
            proliferative breast cancers [
            <span ref-type="bibr" rid="B38">
               <sup>
                  <a href="#B38">20</a>
               </sup>
            </span>]. In fact, Notch signalling activation has even been observed in preinvasive breast
            lesions, including usual ductal hyperplasia (UDH) and ductal carcinoma
            <i> in situ</i> (DCIS) [
            <span ref-type="bibr" rid="B35">
               <sup>
                  <a href="#B35">11</a>
               </sup>
            </span>, 
            <span ref-type="bibr" rid="B59">
               <sup>
                  <a href="#B59">19</a>
               </sup>
            </span>, 
            <span ref-type="bibr" rid="B13">
               <sup>
                  <a href="#B13">21</a>
               </sup>
            </span>]. Lastly, a very recent study has identified a series of activating mutations within
            the PEST domain of Notch1, Notch2, and Notch3 [
            <span ref-type="bibr" rid="B56">
               <sup>
                  <a href="#B56">22</a>
               </sup>
            </span>]. These mutations were enriched in triple negative breast cancers.
         </p>
         <p>The tumour promoting activity of Notch is evident from transgenic mouse model studies.
            For example, Notch4 intracellular domain when expressed under the control of the whey
            acidic promoter (WAP) or Notch1, Notch3, or Notch4 intracellular domains under the
            control of the mouse mammary tumour virus (MMTV) promoter all cause tumour formation
            in mice [
            <span ref-type="bibr" rid="B14">
               <sup>
                  <a href="#B14">23</a>
               </sup>
            </span>–
            <span ref-type="bibr" rid="B25">
               <sup>
                  <a href="#B25">26</a>
               </sup>
            </span>]. Also, conditional deletion of Lunatic Fringe in the mammary gland leads to elevated
            Jagged1-induced Notch signalling and formation of basal-like mammary tumours [
            <span ref-type="bibr" rid="B57">
               <sup>
                  <a href="#B57">27</a>
               </sup>
            </span>].
         </p>
      </div>
      <div tagxxx="sec">
         <title>3. Notch Signalling Regulates Many Cellular Properties of Breast Cancer</title>
         <p>Notch signalling is known to regulate many cellular processes including proliferation
            [
            <span ref-type="bibr" rid="B46">
               <sup>
                  <a href="#B46">17</a>
               </sup>
            </span>, 
            <span ref-type="bibr" rid="B28">
               <sup>
                  <a href="#B28">28</a>
               </sup>
            </span>], apoptosis [
            <span ref-type="bibr" rid="B54">
               <sup>
                  <a href="#B54">16</a>
               </sup>
            </span>, 
            <span ref-type="bibr" rid="B33">
               <sup>
                  <a href="#B33">29</a>
               </sup>
            </span>], angiogenesis [
            <span ref-type="bibr" rid="B60">
               <sup>
                  <a href="#B60">30</a>
               </sup>
            </span>, 
            <span ref-type="bibr" rid="B11">
               <sup>
                  <a href="#B11">31</a>
               </sup>
            </span>], hypoxia [
            <span ref-type="bibr" rid="B18">
               <sup>
                  <a href="#B18">32</a>
               </sup>
            </span>], cancer stem cell activity [
            <span ref-type="bibr" rid="B13">
               <sup>
                  <a href="#B13">21</a>
               </sup>
            </span>, 
            <span ref-type="bibr" rid="B19">
               <sup>
                  <a href="#B19">33</a>
               </sup>
            </span>, 
            <span ref-type="bibr" rid="B17">
               <sup>
                  <a href="#B17">34</a>
               </sup>
            </span>], epithelial-to-mesenchymal transition (EMT) [
            <span ref-type="bibr" rid="B27">
               <sup>
                  <a href="#B27">3</a>
               </sup>
            </span>], and metastasis [
            <span ref-type="bibr" rid="B49">
               <sup>
                  <a href="#B49">35</a>
               </sup>
            </span>]. Notch signalling promotes proliferation in breast cancer cell lines by upregulating
            <i> cyclinA</i>,
            <i> cyclinB,</i> and
            <i> cyclinD1</i> expression [
            <span ref-type="bibr" rid="B4">
               <sup>
                  <a href="#B4">2</a>
               </sup>
            </span>, 
            <span ref-type="bibr" rid="B46">
               <sup>
                  <a href="#B46">17</a>
               </sup>
            </span>, 
            <span ref-type="bibr" rid="B30">
               <sup>
                  <a href="#B30">36</a>
               </sup>
            </span>]. Notch protects breast epithelial cells from apoptosis by activating Akt [
            <span ref-type="bibr" rid="B54">
               <sup>
                  <a href="#B54">16</a>
               </sup>
            </span>, 
            <span ref-type="bibr" rid="B33">
               <sup>
                  <a href="#B33">29</a>
               </sup>
            </span>, 
            <span ref-type="bibr" rid="B6">
               <sup>
                  <a href="#B6">37</a>
               </sup>
            </span>]. It is thought that activation of Akt by Notch in this context occurs through downregulation
            of PTEN expression or secretion of an autocrine signalling protein [
            <span ref-type="bibr" rid="B33">
               <sup>
                  <a href="#B33">29</a>
               </sup>
            </span>, 
            <span ref-type="bibr" rid="B30">
               <sup>
                  <a href="#B30">36</a>
               </sup>
            </span>]. Jagged1, expressed in tumour cells, has been shown to activate Notch signalling
            in neighbouring endothelial cells to promote angiogenesis [
            <span ref-type="bibr" rid="B60">
               <sup>
                  <a href="#B60">30</a>
               </sup>
            </span>]. Notch signalling can also regulate angiogenesis by limiting the number of tip cells
            formed and by promoting the arterial cell fate [
            <span ref-type="bibr" rid="B11">
               <sup>
                  <a href="#B11">31</a>
               </sup>
            </span>]. Notch signalling also regulates the self-renewal of breast cancer stem cells [
            <span ref-type="bibr" rid="B13">
               <sup>
                  <a href="#B13">21</a>
               </sup>
            </span>, 
            <span ref-type="bibr" rid="B17">
               <sup>
                  <a href="#B17">34</a>
               </sup>
            </span>]. In this role, Notch4 appears to be particularly important, as knockdown of Notch4
            has a much more significant effect on breast cancer stem cell numbers than Notch1
            knockdown [
            <span ref-type="bibr" rid="B17">
               <sup>
                  <a href="#B17">34</a>
               </sup>
            </span>]. Notch activity induces EMT by means of RBPj binding to promoter sequences upstream
            of the
            <i> Slug</i> gene [
            <span ref-type="bibr" rid="B27">
               <sup>
                  <a href="#B27">3</a>
               </sup>
            </span>]. Lastly, Notch activity has been shown to induce metastasis of breast cancer cells
            to the bone [
            <span ref-type="bibr" rid="B49">
               <sup>
                  <a href="#B49">35</a>
               </sup>
            </span>]. In this elegant study, the breast cancer cell line MDA-MB-231 was forced to express
            the Notch ligand Jagged1, and this was found to significantly increase bone metastasis
            [
            <span ref-type="bibr" rid="B49">
               <sup>
                  <a href="#B49">35</a>
               </sup>
            </span>]. Altogether, it is very clear that activation of Notch plays a key role in breast
            cancer. Therefore it represents a very attractive therapeutic target.
         </p>
      </div>
      <div tagxxx="sec">
         <title>4. Endocrine Therapy and Targeting Notch in Breast Cancer</title>
         <p>Current breast cancer treatments include general chemotherapeutic drugs such as epirubicin,
            doxorubicin, paclitaxel, and docetaxel, each aiming at blocking the proliferation
            of breast cancer cells. On the other hand, targeted therapies aim to disrupt the function
            of a protein or pathway known to drive tumour growth. Three out of four breast cancers
            express the oestrogen receptor (ER) alpha, and most of these depend on oestrogen for
            growth [
            <span ref-type="bibr" rid="B2">
               <sup>
                  <a href="#B2">38</a>
               </sup>
            </span>]. Consequently, targeting the function of ER is one of the most effective approaches
            to treat breast cancer [
            <span ref-type="bibr" rid="B36">
               <sup>
                  <a href="#B36">39</a>
               </sup>
            </span>]. Therapies against ER
            <i>α</i> +ve breast cancer include antioestrogens and aromatase inhibitors (AIs) [
            <span ref-type="bibr" rid="B10">
               <sup>
                  <a href="#B10">40</a>
               </sup>
            </span>]. Tamoxifen, which antagonises the action of ER by competing for the ligand-binding
            domain of the receptor, is the prevalent endocrine therapy of choice [
            <span ref-type="bibr" rid="B24">
               <sup>
                  <a href="#B24">41</a>
               </sup>
            </span>]. Other antioestrogens, such as pure antioestrogens or AIs, are considered to be
            a good choice when tamoxifen treatment fails [
            <span ref-type="bibr" rid="B22">
               <sup>
                  <a href="#B22">42</a>
               </sup>
            </span>]. AIs are also used in postmenopausal women without ovarian function and act by blocking
            the synthesis of oestrogen from androgens in the peripheral tissues [
            <span ref-type="bibr" rid="B34">
               <sup>
                  <a href="#B34">43</a>
               </sup>
            </span>]. Pure antioestrogens, like fulvestrant, block dimerization of the receptor and lead
            to ubiquitination and proteasome-mediated degradation of the receptor [
            <span ref-type="bibr" rid="B3">
               <sup>
                  <a href="#B3">44</a>
               </sup>
            </span>].
         </p>
         <p>Unfortunately, ER-positive tumours frequently develop resistance to endocrine treatments
            and relapse. Although downregulation of ER expression can contribute to endocrine
            resistance, loss of the receptor during the acquisition of resistance is not commonly
            observed. Several recent studies have suggested that ER mutations, such as a tyrosine
            to asparagine substitution at residue 537 (Y537N), may occur during endocrine treatment
            [
            <span ref-type="bibr" rid="B48">
               <sup>
                  <a href="#B48">45</a>
               </sup>
            </span>, 
            <span ref-type="bibr" rid="B55">
               <sup>
                  <a href="#B55">46</a>
               </sup>
            </span>]. These mutations activate ER and as a consequence lead to a loss of endocrine therapy
            responsiveness. The overexpression of different growth factor receptors and the activation
            of their downstream signalling pathways are also involved in the acquisition of endocrine
            resistance. Tumours resistant to tamoxifen are often associated with high expression
            and enhanced activity of tyrosine kinase receptors EGFR and HER2 [
            <span ref-type="bibr" rid="B15">
               <sup>
                  <a href="#B15">47</a>
               </sup>
            </span>]. These receptors activate kinases, such as ERK1/2, PI3K, and AKT, which promote
            phosphorylation and ligand independent activation of ER [
            <span ref-type="bibr" rid="B2">
               <sup>
                  <a href="#B2">38</a>
               </sup>
            </span>].
         </p>
         <p>Over the past few years, there is accumulating evidence to suggest that cells with
            stem cell properties are the main driving force of tumourigenesis. Al-Hajj and colleagues
            were the first to show that a subpopulation of breast cancer cells, defined by a CD44+/ESA+/CD24lo
            cell surface phenotype, was capable of recapitulating the original tumour phenotype
            when transplanted into nonobese diabetic/severe combined immunodeficient (NOD/SCID)
            mice [
            <span ref-type="bibr" rid="B1">
               <sup>
                  <a href="#B1">48</a>
               </sup>
            </span>]. Since then, several groups have shown that breast tumours behave like an aberrant
            version of normal tissue and organise themselves into a cellular hierarchy with a
            cancer stem-like cell (CSC) at its apex. Indeed, expression of aldehyde dehydrogenase
            (ALDH), a stem/progenitor cell marker, has also been used to enrich for tumour-initiating
            CSCs [
            <span ref-type="bibr" rid="B16">
               <sup>
                  <a href="#B16">49</a>
               </sup>
            </span>]. The concept of CSCs has significant clinical implications, because these cells
            are believed to be responsible for tumour initiation and growth and are often resistant
            to chemo- and radiotherapy. In breast cancer, CD44+/ESA+/CD24lo cells are relatively
            insensitive to conventional chemotherapy and to radiation [
            <span ref-type="bibr" rid="B29">
               <sup>
                  <a href="#B29">50</a>
               </sup>
            </span>, 
            <span ref-type="bibr" rid="B9">
               <sup>
                  <a href="#B9">51</a>
               </sup>
            </span>].
         </p>
         <p>Regarding endocrine therapy, there is accumulating evidence to suggest that an increase
            in breast CSCs occurs following endocrine therapy for ER
            <i>α</i> +ve tumours [
            <span ref-type="bibr" rid="B51">
               <sup>
                  <a href="#B51">52</a>
               </sup>
            </span>]. For example, Creighton and colleagues saw enrichment of cells with breast CSC features
            in tumour tissue derived from patients following therapy with an aromatase inhibitor
            (letrozole) [
            <span ref-type="bibr" rid="B5">
               <sup>
                  <a href="#B5">53</a>
               </sup>
            </span>]. Four other studies showed enrichment for CSC populations in ER
            <i>α</i> +ve breast cancer cell lines after tamoxifen treatment or oestrogen deprivation [
            <span ref-type="bibr" rid="B20">
               <sup>
                  <a href="#B20">18</a>
               </sup>
            </span>, 
            <span ref-type="bibr" rid="B53">
               <sup>
                  <a href="#B53">54</a>
               </sup>
            </span>–
            <span ref-type="bibr" rid="B52">
               <sup>
                  <a href="#B52">56</a>
               </sup>
            </span>]. The potential involvement of CSCs in breast cancer makes it imperative to further
            characterize these cells in order to find cellular signalling pathways that can be
            targeted to eradicate breast CSCs and, therefore, provide long-term disease-free survival.
         </p>
         <p>One strong candidate pathway in this regard is the Notch pathway [
            <span ref-type="bibr" rid="B13">
               <sup>
                  <a href="#B13">21</a>
               </sup>
            </span>]. Pharmacologic and genetic inhibition of the Notch signalling can reduce breast
            CSC activity
            <i> in vitro</i> and tumour formation
            <i> in vivo</i>. Notch4 plays a particular key role in controlling breast CSCs [
            <span ref-type="bibr" rid="B17">
               <sup>
                  <a href="#B17">34</a>
               </sup>
            </span>]. In addition, it has also been reported that overexpression of specific Notch receptors
            is associated with treatment resistance in human breast cancer [
            <span ref-type="bibr" rid="B32">
               <sup>
                  <a href="#B32">57</a>
               </sup>
            </span>]. Likewise, it was shown that the use of antioestrogens can activate Notch signalling
            in breast cancer cells [
            <span ref-type="bibr" rid="B46">
               <sup>
                  <a href="#B46">17</a>
               </sup>
            </span>]. More recently Notch pathway was found to be hyperactivated in endocrine resistant
            breast cancer cells, and its inhibition blocked growth of these cells [
            <span ref-type="bibr" rid="B31">
               <sup>
                  <a href="#B31">58</a>
               </sup>
            </span>, 
            <span ref-type="bibr" rid="B58">
               <sup>
                  <a href="#B58">59</a>
               </sup>
            </span>]. Moreover, we recently demonstrated that increased JAG1-NOTCH4 signalling in human
            breast tumours is an important driver of cancer stem cells [
            <span ref-type="bibr" rid="B52">
               <sup>
                  <a href="#B52">56</a>
               </sup>
            </span>].
         </p>
         <p>Besides Notch signalling, other CSC pathways are aberrantly activated in endocrine
            resistant cells. For example, Wnt and Hedgehog signalling pathways are active in CSCs
            and this has already been shown to promote tamoxifen resistance [
            <span ref-type="bibr" rid="B41">
               <sup>
                  <a href="#B41">55</a>
               </sup>
            </span>, 
            <span ref-type="bibr" rid="B42">
               <sup>
                  <a href="#B42">60</a>
               </sup>
            </span>]. Together these results suggest that inhibiting CSC signalling pathways will help
            to overcome endocrine therapy resistance and recurrence in ER
            <i>α</i> +ve breast cancer.
         </p>
      </div>
      <div tagxxx="sec">
         <title>5. Conclusion</title>
         <p>It is widely recognized that increased Notch signalling is one of the main drivers
            of cellular malignancies in breast cancer. Moreover, Notch pathway activation is commonly
            seen in response to targeted therapies. Therefore, combining current treatment options
            with a blockade of Notch signalling might be a feasible approach to consider. With
            this being said, individual Notch receptors are likely to regulate mammary epithelial
            and breast cancer cells in unique ways; hence it is vital to delineate the functional
            role for individual Notch receptors in mediating resistance to therapy in breast cancer.
         </p>
      </div>
      <back>
         <div tagxxx="ack">
            <title>Acknowledgment</title>
            <p>The authors would like to thank Breast Cancer Now for their support of their laboratories.</p>
         </div>
         <div tagxxx="sec">
            <title>Conflict of Interests</title>
            <p>The authors declare no conflict of interests.</p>
         </div>
         <div tag="ref-list">
            <ul>
               <li tag="ref">
                  <a name="B43"></a>
                  <label>1</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Ranganathan</span>
                           <span tagx="given-names">P.</span>
                        </name>
                        <name>
                           <span tagx="surname">Weaver</span>
                           <span tagx="given-names">K. L.</span>
                        </name>
                        <name>
                           <span tagx="surname">Capobianco</span>
                           <span tagx="given-names">A. J.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Notch signalling in solid tumours: a little bit of everything but not all the time</span>
                     <span tagx="source">
                        <i>Nature Reviews Cancer</i>
                     </span>
                     <span tagx="year">2011</span>
                     <span tagx="volume">11</span>
                     <div tagxxx="issue">5</div>
                     <span tagx="fpage">338</span>
                     <span tagx="lpage">351</span>
                     <span class="pub-id'">[10.1038/nrc3035]</span>
                     <span class="pub-id'">[2-s2.0-79955460636]</span>
                     <span class="pub-id'">[21508972]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B4"></a>
                  <label>2</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Cohen</span>
                           <span tagx="given-names">B.</span>
                        </name>
                        <name>
                           <span tagx="surname">Shimizu</span>
                           <span tagx="given-names">M.</span>
                        </name>
                        <name>
                           <span tagx="surname">Izrailit</span>
                           <span tagx="given-names">J.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Cyclin D1 is a direct target of JAG1-mediated Notch signaling in breast cancer</span>
                     <span tagx="source">
                        <i>Breast Cancer Research and Treatment</i>
                     </span>
                     <span tagx="year">2010</span>
                     <span tagx="volume">123</span>
                     <div tagxxx="issue">1</div>
                     <span tagx="fpage">113</span>
                     <span tagx="lpage">124</span>
                     <span class="pub-id'">[10.1007/s10549-009-0621-9]</span>
                     <span class="pub-id'">[2-s2.0-77955768470]</span>
                     <span class="pub-id'">[19915977]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B27"></a>
                  <label>3</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Leong</span>
                           <span tagx="given-names">K. G.</span>
                        </name>
                        <name>
                           <span tagx="surname">Niessen</span>
                           <span tagx="given-names">K.</span>
                        </name>
                        <name>
                           <span tagx="surname">Kulic</span>
                           <span tagx="given-names">I.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Jagged1-mediated Notch activation induces epithelial-to-mesenchymal transition through
                        Slug-induced repression of E-cadherin
                     </span>
                     <span tagx="source">
                        <i>The Journal of Experimental Medicine</i>
                     </span>
                     <span tagx="year">2007</span>
                     <span tagx="volume">204</span>
                     <div tagxxx="issue">12</div>
                     <span tagx="fpage">2935</span>
                     <span tagx="lpage">2948</span>
                     <span class="pub-id'">[10.1084/jem.20071082]</span>
                     <span class="pub-id'">[2-s2.0-36549010842]</span>
                     <span class="pub-id'">[17984306]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B50"></a>
                  <label>4</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Shi</span>
                           <span tagx="given-names">S.</span>
                        </name>
                        <name>
                           <span tagx="surname">Stanley</span>
                           <span tagx="given-names">P.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Protein O-fucosyltransferase 1 is an essential component of Notch signaling pathways</span>
                     <span tagx="source">
                        <i>Proceedings of the National Academy of Sciences of the United States of America</i>
                     </span>
                     <span tagx="year">2003</span>
                     <span tagx="volume">100</span>
                     <div tagxxx="issue">9</div>
                     <span tagx="fpage">5234</span>
                     <span tagx="lpage">5239</span>
                     <span class="pub-id'">[10.1073/pnas.0831126100]</span>
                     <span class="pub-id'">[2-s2.0-0037547158]</span>
                     <span class="pub-id'">[12697902]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B37"></a>
                  <label>5</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Panin</span>
                           <span tagx="given-names">V. M.</span>
                        </name>
                        <name>
                           <span tagx="surname">Papayannopoulos</span>
                           <span tagx="given-names">V.</span>
                        </name>
                        <name>
                           <span tagx="surname">Wilson</span>
                           <span tagx="given-names">R.</span>
                        </name>
                        <name>
                           <span tagx="surname">Irvine</span>
                           <span tagx="given-names">K. D.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Fringe modulates Notch-ligand interactions</span>
                     <span tagx="source">
                        <i>Nature</i>
                     </span>
                     <span tagx="year">1997</span>
                     <span tagx="volume">387</span>
                     <div tagxxx="issue">6636</div>
                     <span tagx="fpage">908</span>
                     <span tagx="lpage">912</span>
                     <span class="pub-id'">[10.1038/43191]</span>
                     <span class="pub-id'">[2-s2.0-0030756962]</span>
                     <span class="pub-id'">[9202123]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B12"></a>
                  <label>6</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Espinosa</span>
                           <span tagx="given-names">L.</span>
                        </name>
                        <name>
                           <span tagx="surname">Inglés-Esteve</span>
                           <span tagx="given-names">J.</span>
                        </name>
                        <name>
                           <span tagx="surname">Aguilera</span>
                           <span tagx="given-names">C.</span>
                        </name>
                        <name>
                           <span tagx="surname">Bigas</span>
                           <span tagx="given-names">A.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Phosphorylation by glycogen synthase kinase-3
                        <i>β</i> down-regulates Notch activity, a link for Notch and Wnt pathways
                     </span>
                     <span tagx="source">
                        <i>The Journal of Biological Chemistry</i>
                     </span>
                     <span tagx="year">2003</span>
                     <span tagx="volume">278</span>
                     <div tagxxx="issue">34</div>
                     <span tagx="fpage">32227</span>
                     <span tagx="lpage">32235</span>
                     <span class="pub-id'">[10.1074/jbc.m304001200]</span>
                     <span class="pub-id'">[2-s2.0-0041856097]</span>
                     <span class="pub-id'">[12794074]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B26"></a>
                  <label>7</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Le Bras</span>
                           <span tagx="given-names">S.</span>
                        </name>
                        <name>
                           <span tagx="surname">Loyer</span>
                           <span tagx="given-names">N.</span>
                        </name>
                        <name>
                           <span tagx="surname">Le Borgne</span>
                           <span tagx="given-names">R.</span>
                        </name>
                     </span>
                     <span tagx="article-title">The multiple facets of ubiquitination in the regulation of notch signaling pathway</span>
                     <span tagx="source">
                        <i>Traffic</i>
                     </span>
                     <span tagx="year">2011</span>
                     <span tagx="volume">12</span>
                     <div tagxxx="issue">2</div>
                     <span tagx="fpage">149</span>
                     <span tagx="lpage">161</span>
                     <span class="pub-id'">[10.1111/j.1600-0854.2010.01126.x]</span>
                     <span class="pub-id'">[2-s2.0-78651093198]</span>
                     <span class="pub-id'">[21029288]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B40"></a>
                  <label>8</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Perou</span>
                           <span tagx="given-names">C. M.</span>
                        </name>
                        <name>
                           <span tagx="surname">Sørile</span>
                           <span tagx="given-names">T.</span>
                        </name>
                        <name>
                           <span tagx="surname">Eisen</span>
                           <span tagx="given-names">M. B.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Molecular portraits of human breast tumours</span>
                     <span tagx="source">
                        <i>Nature</i>
                     </span>
                     <span tagx="year">2000</span>
                     <span tagx="volume">406</span>
                     <div tagxxx="issue">6797</div>
                     <span tagx="fpage">747</span>
                     <span tagx="lpage">752</span>
                     <span class="pub-id'">[10.1038/35021093]</span>
                     <span class="pub-id'">[2-s2.0-0034680102]</span>
                     <span class="pub-id'">[10963602]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B21"></a>
                  <label>9</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Herschkowitz</span>
                           <span tagx="given-names">J. I.</span>
                        </name>
                        <name>
                           <span tagx="surname">Simin</span>
                           <span tagx="given-names">K.</span>
                        </name>
                        <name>
                           <span tagx="surname">Weigman</span>
                           <span tagx="given-names">V. J.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Identification of conserved gene expression features between murine mammary carcinoma
                        models and human breast tumors
                     </span>
                     <span tagx="source">
                        <i>Genome Biology</i>
                     </span>
                     <span tagx="year">2007</span>
                     <span tagx="volume">8</span>
                     <div tagxxx="issue">5, article R76</div>
                     <span class="pub-id'">[10.1186/gb-2007-8-5-r76]</span>
                     <span class="pub-id'">[2-s2.0-34548863946]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B7"></a>
                  <label>10</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Dawson</span>
                           <span tagx="given-names">S.-J.</span>
                        </name>
                        <name>
                           <span tagx="surname">Rueda</span>
                           <span tagx="given-names">O. M.</span>
                        </name>
                        <name>
                           <span tagx="surname">Aparicio</span>
                           <span tagx="given-names">S.</span>
                        </name>
                        <name>
                           <span tagx="surname">Caldas</span>
                           <span tagx="given-names">C.</span>
                        </name>
                     </span>
                     <span tagx="article-title">A new genome-driven integrated classification of breast cancer and its implications</span>
                     <span tagx="source">
                        <i>The EMBO Journal</i>
                     </span>
                     <span tagx="year">2013</span>
                     <span tagx="volume">32</span>
                     <div tagxxx="issue">5</div>
                     <span tagx="fpage">617</span>
                     <span tagx="lpage">628</span>
                     <span class="pub-id'">[10.1038/emboj.2013.19]</span>
                     <span class="pub-id'">[2-s2.0-84875217358]</span>
                     <span class="pub-id'">[23395906]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B35"></a>
                  <label>11</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Mittal</span>
                           <span tagx="given-names">S.</span>
                        </name>
                        <name>
                           <span tagx="surname">Subramanyam</span>
                           <span tagx="given-names">D.</span>
                        </name>
                        <name>
                           <span tagx="surname">Dey</span>
                           <span tagx="given-names">D.</span>
                        </name>
                        <name>
                           <span tagx="surname">Kumar</span>
                           <span tagx="given-names">R. V.</span>
                        </name>
                        <name>
                           <span tagx="surname">Rangarajan</span>
                           <span tagx="given-names">A.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Cooperation of Notch and Ras/MAPK signaling pathways in human breast carcinogenesis</span>
                     <span tagx="source">
                        <i>Molecular Cancer</i>
                     </span>
                     <span tagx="year">2009</span>
                     <span tagx="volume">8, article 128</span>
                     <span class="pub-id'">[10.1186/1476-4598-8-128]</span>
                     <span class="pub-id'">[2-s2.0-74549133972]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B44"></a>
                  <label>12</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Reedijk</span>
                           <span tagx="given-names">M.</span>
                        </name>
                        <name>
                           <span tagx="surname">Odorcic</span>
                           <span tagx="given-names">S.</span>
                        </name>
                        <name>
                           <span tagx="surname">Chang</span>
                           <span tagx="given-names">L.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and
                        is associated with poor overall survival
                     </span>
                     <span tagx="source">
                        <i>Cancer Research</i>
                     </span>
                     <span tagx="year">2005</span>
                     <span tagx="volume">65</span>
                     <div tagxxx="issue">18</div>
                     <span tagx="fpage">8530</span>
                     <span tagx="lpage">8537</span>
                     <span class="pub-id'">[10.1158/0008-5472.can-05-1069]</span>
                     <span class="pub-id'">[2-s2.0-24944506696]</span>
                     <span class="pub-id'">[16166334]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B45"></a>
                  <label>13</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Reedijk</span>
                           <span tagx="given-names">M.</span>
                        </name>
                        <name>
                           <span tagx="surname">Pinnaduwage</span>
                           <span tagx="given-names">D.</span>
                        </name>
                        <name>
                           <span tagx="surname">Dickson</span>
                           <span tagx="given-names">B. C.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">JAG1 expression is associated with a basal phenotype and recurrence in lymph node-negative
                        breast cancer
                     </span>
                     <span tagx="source">
                        <i>Breast Cancer Research and Treatment</i>
                     </span>
                     <span tagx="year">2008</span>
                     <span tagx="volume">111</span>
                     <div tagxxx="issue">3</div>
                     <span tagx="fpage">439</span>
                     <span tagx="lpage">448</span>
                     <span class="pub-id'">[10.1007/s10549-007-9805-3]</span>
                     <span class="pub-id'">[2-s2.0-51649090695]</span>
                     <span class="pub-id'">[17990101]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B8"></a>
                  <label>14</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Dickson</span>
                           <span tagx="given-names">B. C.</span>
                        </name>
                        <name>
                           <span tagx="surname">Mulligan</span>
                           <span tagx="given-names">A. M.</span>
                        </name>
                        <name>
                           <span tagx="surname">Zhang</span>
                           <span tagx="given-names">H.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">High-level JAG1 mRNA and protein predict poor outcome in breast cancer</span>
                     <span tagx="source">
                        <i>Modern Pathology</i>
                     </span>
                     <span tagx="year">2007</span>
                     <span tagx="volume">20</span>
                     <div tagxxx="issue">6</div>
                     <span tagx="fpage">685</span>
                     <span tagx="lpage">693</span>
                     <span class="pub-id'">[10.1038/modpathol.3800785]</span>
                     <span class="pub-id'">[2-s2.0-34249098132]</span>
                     <span class="pub-id'">[17507991]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B39"></a>
                  <label>15</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Pece</span>
                           <span tagx="given-names">S.</span>
                        </name>
                        <name>
                           <span tagx="surname">Serresi</span>
                           <span tagx="given-names">M.</span>
                        </name>
                        <name>
                           <span tagx="surname">Santolini</span>
                           <span tagx="given-names">E.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis</span>
                     <span tagx="source">
                        <i>Journal of Cell Biology</i>
                     </span>
                     <span tagx="year">2004</span>
                     <span tagx="volume">167</span>
                     <div tagxxx="issue">2</div>
                     <span tagx="fpage">215</span>
                     <span tagx="lpage">221</span>
                     <span class="pub-id'">[10.1083/jcb.200406140]</span>
                     <span class="pub-id'">[2-s2.0-7244250027]</span>
                     <span class="pub-id'">[15492044]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B54"></a>
                  <label>16</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Stylianou</span>
                           <span tagx="given-names">S.</span>
                        </name>
                        <name>
                           <span tagx="surname">Clarke</span>
                           <span tagx="given-names">R. B.</span>
                        </name>
                        <name>
                           <span tagx="surname">Brennan</span>
                           <span tagx="given-names">K.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Aberrant activation of notch signaling in human breast cancer</span>
                     <span tagx="source">
                        <i>Cancer Research</i>
                     </span>
                     <span tagx="year">2006</span>
                     <span tagx="volume">66</span>
                     <div tagxxx="issue">3</div>
                     <span tagx="fpage">1517</span>
                     <span tagx="lpage">1525</span>
                     <span class="pub-id'">[10.1158/0008-5472.can-05-3054]</span>
                     <span class="pub-id'">[2-s2.0-32944470488]</span>
                     <span class="pub-id'">[16452208]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B46"></a>
                  <label>17</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Rizzo</span>
                           <span tagx="given-names">P.</span>
                        </name>
                        <name>
                           <span tagx="surname">Miao</span>
                           <span tagx="given-names">H.</span>
                        </name>
                        <name>
                           <span tagx="surname">D'Souza</span>
                           <span tagx="given-names">G.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Cross-talk between notch and the estrogen receptor in breast cancer suggests novel
                        therapeutic approaches
                     </span>
                     <span tagx="source">
                        <i>Cancer Research</i>
                     </span>
                     <span tagx="year">2008</span>
                     <span tagx="volume">68</span>
                     <div tagxxx="issue">13</div>
                     <span tagx="fpage">5226</span>
                     <span tagx="lpage">5235</span>
                     <span class="pub-id'">[10.1158/0008-5472.can-07-5744]</span>
                     <span class="pub-id'">[2-s2.0-48549103124]</span>
                     <span class="pub-id'">[18593923]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B20"></a>
                  <label>18</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Haughian</span>
                           <span tagx="given-names">J. M.</span>
                        </name>
                        <name>
                           <span tagx="surname">Pinto</span>
                           <span tagx="given-names">M. P.</span>
                        </name>
                        <name>
                           <span tagx="surname">Harrell</span>
                           <span tagx="given-names">J. C.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Maintenance of hormone responsiveness in luminal breast cancers by suppression of
                        Notch
                     </span>
                     <span tagx="source">
                        <i>Proceedings of the National Academy of Sciences of the United States of America</i>
                     </span>
                     <span tagx="year">2012</span>
                     <span tagx="volume">109</span>
                     <div tagxxx="issue">8</div>
                     <span tagx="fpage">2742</span>
                     <span tagx="lpage">2747</span>
                     <span class="pub-id'">[10.1073/pnas.1106509108]</span>
                     <span class="pub-id'">[2-s2.0-84857398226]</span>
                     <span class="pub-id'">[21969591]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B59"></a>
                  <label>19</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Zardawi</span>
                           <span tagx="given-names">S. J.</span>
                        </name>
                        <name>
                           <span tagx="surname">Zardawi</span>
                           <span tagx="given-names">I.</span>
                        </name>
                        <name>
                           <span tagx="surname">McNeil</span>
                           <span tagx="given-names">C. M.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">High Notch1 protein expression is an early event in breast cancer development and
                        is associated with the HER-2 molecular subtype
                     </span>
                     <span tagx="source">
                        <i>Histopathology</i>
                     </span>
                     <span tagx="year">2010</span>
                     <span tagx="volume">56</span>
                     <div tagxxx="issue">3</div>
                     <span tagx="fpage">286</span>
                     <span tagx="lpage">296</span>
                     <span class="pub-id'">[10.1111/j.1365-2559.2009.03475.x]</span>
                     <span class="pub-id'">[2-s2.0-77449089220]</span>
                     <span class="pub-id'">[20459529]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B38"></a>
                  <label>20</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Parr</span>
                           <span tagx="given-names">C.</span>
                        </name>
                        <name>
                           <span tagx="surname">Watkins</span>
                           <span tagx="given-names">G.</span>
                        </name>
                        <name>
                           <span tagx="surname">Jiang</span>
                           <span tagx="given-names">W. G.</span>
                        </name>
                     </span>
                     <span tagx="article-title">The possible correlation of Notch-1 and Notch-2 with clinical outcome and tumour clinicopathological
                        parameters in human breast cancer
                     </span>
                     <span tagx="source">
                        <i>International Journal of Molecular Medicine</i>
                     </span>
                     <span tagx="year">2004</span>
                     <span tagx="volume">14</span>
                     <div tagxxx="issue">5</div>
                     <span tagx="fpage">779</span>
                     <span tagx="lpage">786</span>
                     <span class="pub-id'">[2-s2.0-14244269366]</span>
                     <span class="pub-id'">[15492845]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B13"></a>
                  <label>21</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Farnie</span>
                           <span tagx="given-names">G.</span>
                        </name>
                        <name>
                           <span tagx="surname">Clarke</span>
                           <span tagx="given-names">R. B.</span>
                        </name>
                        <name>
                           <span tagx="surname">Spence</span>
                           <span tagx="given-names">K.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Novel cell culture technique for primary ductal carcinoma in situ: role of Notch and
                        epidermal growth factor receptor signaling pathways
                     </span>
                     <span tagx="source">
                        <i>Journal of the National Cancer Institute</i>
                     </span>
                     <span tagx="year">2007</span>
                     <span tagx="volume">99</span>
                     <div tagxxx="issue">8</div>
                     <span tagx="fpage">616</span>
                     <span tagx="lpage">627</span>
                     <span class="pub-id'">[10.1093/jnci/djk133]</span>
                     <span class="pub-id'">[2-s2.0-34247581697]</span>
                     <span class="pub-id'">[17440163]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B56"></a>
                  <label>22</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Wang</span>
                           <span tagx="given-names">K.</span>
                        </name>
                        <name>
                           <span tagx="surname">Zhang</span>
                           <span tagx="given-names">Q.</span>
                        </name>
                        <name>
                           <span tagx="surname">Li</span>
                           <span tagx="given-names">D.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">PEST domain mutations in Notch receptors comprise an oncogenic driver segment in triple-negative
                        breast cancer sensitive to a gamma-secretase inhibitor
                     </span>
                     <span tagx="source">
                        <i>Clinical Cancer Research</i>
                     </span>
                     <span tagx="year">2015</span>
                     <span tagx="volume">21</span>
                     <div tagxxx="issue">6</div>
                     <span tagx="fpage">1487</span>
                     <span tagx="lpage">1496</span>
                     <span class="pub-id'">[10.1158/1078-0432.ccr-14-1348]</span>
                     <span class="pub-id'">[25564152]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B14"></a>
                  <label>23</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Gallahan</span>
                           <span tagx="given-names">D.</span>
                        </name>
                        <name>
                           <span tagx="surname">Jhappan</span>
                           <span tagx="given-names">C.</span>
                        </name>
                        <name>
                           <span tagx="surname">Robinson</span>
                           <span tagx="given-names">G.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Expression of a truncated Int3 gene in developing secretory mammary epithelium specifically
                        retards lobular differentiation resulting in tumorigenesis
                     </span>
                     <span tagx="source">
                        <i>Cancer Research</i>
                     </span>
                     <span tagx="year">1996</span>
                     <span tagx="volume">56</span>
                     <div tagxxx="issue">8</div>
                     <span tagx="fpage">1775</span>
                     <span tagx="lpage">1785</span>
                     <span class="pub-id'">[2-s2.0-0029871104]</span>
                     <span class="pub-id'">[8620493]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B23"></a>
                  <label>24</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Hu</span>
                           <span tagx="given-names">C.</span>
                        </name>
                        <name>
                           <span tagx="surname">Diévart</span>
                           <span tagx="given-names">A.</span>
                        </name>
                        <name>
                           <span tagx="surname">Lupien</span>
                           <span tagx="given-names">M.</span>
                        </name>
                        <name>
                           <span tagx="surname">Calvo</span>
                           <span tagx="given-names">E.</span>
                        </name>
                        <name>
                           <span tagx="surname">Tremblay</span>
                           <span tagx="given-names">G.</span>
                        </name>
                        <name>
                           <span tagx="surname">Jolicoeur</span>
                           <span tagx="given-names">P.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Overexpression of activated murine Notch1 and Notch3 in transgenic mice blocks mammary
                        gland development and induces mammary tumors
                     </span>
                     <span tagx="source">
                        <i>The American Journal of Pathology</i>
                     </span>
                     <span tagx="year">2006</span>
                     <span tagx="volume">168</span>
                     <div tagxxx="issue">3</div>
                     <span tagx="fpage">973</span>
                     <span tagx="lpage">990</span>
                     <span class="pub-id'">[10.2353/ajpath.2006.050416]</span>
                     <span class="pub-id'">[2-s2.0-33644660241]</span>
                     <span class="pub-id'">[16507912]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B47"></a>
                  <label>25</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Robbins</span>
                           <span tagx="given-names">J.</span>
                        </name>
                        <name>
                           <span tagx="surname">Blondel</span>
                           <span tagx="given-names">B. J.</span>
                        </name>
                        <name>
                           <span tagx="surname">Gallahan</span>
                           <span tagx="given-names">D.</span>
                        </name>
                        <name>
                           <span tagx="surname">Callahan</span>
                           <span tagx="given-names">R.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Mouse mammary tumor gene int-3: a member of the notch gene family transforms mammary
                        epithelial cells
                     </span>
                     <span tagx="source">
                        <i>Journal of Virology</i>
                     </span>
                     <span tagx="year">1992</span>
                     <span tagx="volume">66</span>
                     <div tagxxx="issue">4</div>
                     <span tagx="fpage">2594</span>
                     <span tagx="lpage">2599</span>
                     <span class="pub-id'">[2-s2.0-0026554890]</span>
                     <span class="pub-id'">[1312643]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B25"></a>
                  <label>26</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Kiaris</span>
                           <span tagx="given-names">H.</span>
                        </name>
                        <name>
                           <span tagx="surname">Politi</span>
                           <span tagx="given-names">K.</span>
                        </name>
                        <name>
                           <span tagx="surname">Grimm</span>
                           <span tagx="given-names">L. M.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Modulation of notch signaling elicits signature tumors and inhibits Hras1-induced
                        oncogenesis in the mouse mammary epithelium
                     </span>
                     <span tagx="source">
                        <i>The American Journal of Pathology</i>
                     </span>
                     <span tagx="year">2004</span>
                     <span tagx="volume">165</span>
                     <div tagxxx="issue">2</div>
                     <span tagx="fpage">695</span>
                     <span tagx="lpage">705</span>
                     <span class="pub-id'">[10.1016/s0002-9440(10)63333-0]</span>
                     <span class="pub-id'">[2-s2.0-3242805831]</span>
                     <span class="pub-id'">[15277242]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B57"></a>
                  <label>27</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Xu</span>
                           <span tagx="given-names">K.</span>
                        </name>
                        <name>
                           <span tagx="surname">Usary</span>
                           <span tagx="given-names">J.</span>
                        </name>
                        <name>
                           <span tagx="surname">Kousis</span>
                           <span tagx="given-names">P. C.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Lunatic fringe deficiency cooperates with the Met/Caveolin gene amplicon to induce
                        basal-like breast cancer
                     </span>
                     <span tagx="source">
                        <i>Cancer Cell</i>
                     </span>
                     <span tagx="year">2012</span>
                     <span tagx="volume">21</span>
                     <div tagxxx="issue">5</div>
                     <span tagx="fpage">626</span>
                     <span tagx="lpage">641</span>
                     <span class="pub-id'">[10.1016/j.ccr.2012.03.041]</span>
                     <span class="pub-id'">[2-s2.0-84861398396]</span>
                     <span class="pub-id'">[22624713]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B28"></a>
                  <label>28</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Li</span>
                           <span tagx="given-names">K.</span>
                        </name>
                        <name>
                           <span tagx="surname">Li</span>
                           <span tagx="given-names">Y.</span>
                        </name>
                        <name>
                           <span tagx="surname">Wu</span>
                           <span tagx="given-names">W.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Modulation of notch signaling by antibodies specific for the extracellular negative
                        regulatory region of NOTCH3
                     </span>
                     <span tagx="source">
                        <i>The Journal of Biological Chemistry</i>
                     </span>
                     <span tagx="year">2008</span>
                     <span tagx="volume">283</span>
                     <div tagxxx="issue">12</div>
                     <span tagx="fpage">8046</span>
                     <span tagx="lpage">8054</span>
                     <span class="pub-id'">[10.1074/jbc.m800170200]</span>
                     <span class="pub-id'">[2-s2.0-43149113910]</span>
                     <span class="pub-id'">[18182388]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B33"></a>
                  <label>29</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Meurette</span>
                           <span tagx="given-names">O.</span>
                        </name>
                        <name>
                           <span tagx="surname">Stylianou</span>
                           <span tagx="given-names">S.</span>
                        </name>
                        <name>
                           <span tagx="surname">Rock</span>
                           <span tagx="given-names">R.</span>
                        </name>
                        <name>
                           <span tagx="surname">Collu</span>
                           <span tagx="given-names">G. M.</span>
                        </name>
                        <name>
                           <span tagx="surname">Gilmore</span>
                           <span tagx="given-names">A. P.</span>
                        </name>
                        <name>
                           <span tagx="surname">Brennan</span>
                           <span tagx="given-names">K.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Notch activation induces Akt signaling via an autocrine loop to prevent apoptosis
                        in breast epithelial cells
                     </span>
                     <span tagx="source">
                        <i>Cancer Research</i>
                     </span>
                     <span tagx="year">2009</span>
                     <span tagx="volume">69</span>
                     <div tagxxx="issue">12</div>
                     <span tagx="fpage">5015</span>
                     <span tagx="lpage">5022</span>
                     <span class="pub-id'">[10.1158/0008-5472.CAN-08-3478]</span>
                     <span class="pub-id'">[2-s2.0-67449116604]</span>
                     <span class="pub-id'">[19491273]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B60"></a>
                  <label>30</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Zeng</span>
                           <span tagx="given-names">Q.</span>
                        </name>
                        <name>
                           <span tagx="surname">Li</span>
                           <span tagx="given-names">S.</span>
                        </name>
                        <name>
                           <span tagx="surname">Chepeha</span>
                           <span tagx="given-names">D. B.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Crosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK
                        activation of Notch signaling
                     </span>
                     <span tagx="source">
                        <i>Cancer Cell</i>
                     </span>
                     <span tagx="year">2005</span>
                     <span tagx="volume">8</span>
                     <div tagxxx="issue">1</div>
                     <span tagx="fpage">13</span>
                     <span tagx="lpage">23</span>
                     <span class="pub-id'">[10.1016/j.ccr.2005.06.004]</span>
                     <span class="pub-id'">[2-s2.0-22244460522]</span>
                     <span class="pub-id'">[16023595]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B11"></a>
                  <label>31</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Dufraine</span>
                           <span tagx="given-names">J.</span>
                        </name>
                        <name>
                           <span tagx="surname">Funahashi</span>
                           <span tagx="given-names">Y.</span>
                        </name>
                        <name>
                           <span tagx="surname">Kitajewski</span>
                           <span tagx="given-names">J.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Notch signaling regulates tumor angiogenesis by diverse mechanisms</span>
                     <span tagx="source">
                        <i>Oncogene</i>
                     </span>
                     <span tagx="year">2008</span>
                     <span tagx="volume">27</span>
                     <div tagxxx="issue">38</div>
                     <span tagx="fpage">5132</span>
                     <span tagx="lpage">5137</span>
                     <span class="pub-id'">[10.1038/onc.2008.227]</span>
                     <span class="pub-id'">[2-s2.0-50849103301]</span>
                     <span class="pub-id'">[18758482]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B18"></a>
                  <label>32</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Harrison</span>
                           <span tagx="given-names">H.</span>
                        </name>
                        <name>
                           <span tagx="surname">Rogerson</span>
                           <span tagx="given-names">L.</span>
                        </name>
                        <name>
                           <span tagx="surname">Gregson</span>
                           <span tagx="given-names">H. J.</span>
                        </name>
                        <name>
                           <span tagx="surname">Brennan</span>
                           <span tagx="given-names">K. R.</span>
                        </name>
                        <name>
                           <span tagx="surname">Clarke</span>
                           <span tagx="given-names">R. B.</span>
                        </name>
                        <name>
                           <span tagx="surname">Landberg</span>
                           <span tagx="given-names">G.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Contrasting hypoxic effects on breast cancer stem cell hierarchy is dependent on er-a
                        status
                     </span>
                     <span tagx="source">
                        <i>Cancer Research</i>
                     </span>
                     <span tagx="year">2013</span>
                     <span tagx="volume">73</span>
                     <div tagxxx="issue">4</div>
                     <span tagx="fpage">1420</span>
                     <span tagx="lpage">1433</span>
                     <span class="pub-id'">[10.1158/0008-5472.CAN-12-2505]</span>
                     <span class="pub-id'">[2-s2.0-84874299961]</span>
                     <span class="pub-id'">[23248117]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B19"></a>
                  <label>33</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Harrison</span>
                           <span tagx="given-names">H.</span>
                        </name>
                        <name>
                           <span tagx="surname">Simões</span>
                           <span tagx="given-names">B. M.</span>
                        </name>
                        <name>
                           <span tagx="surname">Rogerson</span>
                           <span tagx="given-names">L.</span>
                        </name>
                        <name>
                           <span tagx="surname">Howell</span>
                           <span tagx="given-names">S. J.</span>
                        </name>
                        <name>
                           <span tagx="surname">Landberg</span>
                           <span tagx="given-names">G.</span>
                        </name>
                        <name>
                           <span tagx="surname">Clarke</span>
                           <span tagx="given-names">R. B.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Oestrogen increases the activity of oestrogen receptor negative breast cancer stem
                        cells through paracrine EGFR and Notch signalling
                     </span>
                     <span tagx="source">
                        <i>Breast Cancer Research</i>
                     </span>
                     <span tagx="year">2013</span>
                     <span tagx="volume">15</span>
                     <div tagxxx="issue">2, article R21</div>
                     <span class="pub-id'">[10.1186/bcr3396]</span>
                     <span class="pub-id'">[2-s2.0-84874691352]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B17"></a>
                  <label>34</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Harrison</span>
                           <span tagx="given-names">H.</span>
                        </name>
                        <name>
                           <span tagx="surname">Farnie</span>
                           <span tagx="given-names">G.</span>
                        </name>
                        <name>
                           <span tagx="surname">Howell</span>
                           <span tagx="given-names">S. J.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor</span>
                     <span tagx="source">
                        <i>Cancer Research</i>
                     </span>
                     <span tagx="year">2010</span>
                     <span tagx="volume">70</span>
                     <div tagxxx="issue">2</div>
                     <span tagx="fpage">709</span>
                     <span tagx="lpage">718</span>
                     <span class="pub-id'">[10.1158/0008-5472.can-09-1681]</span>
                     <span class="pub-id'">[2-s2.0-76549084826]</span>
                     <span class="pub-id'">[20068161]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B49"></a>
                  <label>35</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Sethi</span>
                           <span tagx="given-names">N.</span>
                        </name>
                        <name>
                           <span tagx="surname">Dai</span>
                           <span tagx="given-names">X.</span>
                        </name>
                        <name>
                           <span tagx="surname">Winter</span>
                           <span tagx="given-names">C. G.</span>
                        </name>
                        <name>
                           <span tagx="surname">Kang</span>
                           <span tagx="given-names">Y.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Tumor-derived JAGGED1 promotes osteolytic bone metastasis of breast cancer by engaging
                        notch signaling in bone cells
                     </span>
                     <span tagx="source">
                        <i>Cancer Cell</i>
                     </span>
                     <span tagx="year">2011</span>
                     <span tagx="volume">19</span>
                     <div tagxxx="issue">2</div>
                     <span tagx="fpage">192</span>
                     <span tagx="lpage">205</span>
                     <span class="pub-id'">[10.1016/j.ccr.2010.12.022]</span>
                     <span class="pub-id'">[2-s2.0-79751472667]</span>
                     <span class="pub-id'">[21295524]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B30"></a>
                  <label>36</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Ling</span>
                           <span tagx="given-names">H.</span>
                        </name>
                        <name>
                           <span tagx="surname">Sylvestre</span>
                           <span tagx="given-names">J.-R.</span>
                        </name>
                        <name>
                           <span tagx="surname">Jolicoeur</span>
                           <span tagx="given-names">P.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Notch1-induced mammary tumor development is cyclin D1-dependent and correlates with
                        expansion of pre-malignant multipotent duct-limited progenitors
                     </span>
                     <span tagx="source">
                        <i>Oncogene</i>
                     </span>
                     <span tagx="year">2010</span>
                     <span tagx="volume">29</span>
                     <div tagxxx="issue">32</div>
                     <span tagx="fpage">4543</span>
                     <span tagx="lpage">4554</span>
                     <span class="pub-id'">[10.1038/onc.2010.186]</span>
                     <span class="pub-id'">[2-s2.0-77955657847]</span>
                     <span class="pub-id'">[20562911]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B6"></a>
                  <label>37</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Dang</span>
                           <span tagx="given-names">T. P.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Notch, apoptosis and cancer</span>
                     <span tagx="source">
                        <i>Advances in Experimental Medicine and Biology</i>
                     </span>
                     <span tagx="year">2012</span>
                     <span tagx="volume">727</span>
                     <span tagx="fpage">199</span>
                     <span tagx="lpage">209</span>
                     <span class="pub-id'">[10.1007/978-1-4614-0899-4_15]</span>
                     <span class="pub-id'">[2-s2.0-84859485240]</span>
                     <span class="pub-id'">[22399349]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B2"></a>
                  <label>38</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Ali</span>
                           <span tagx="given-names">S.</span>
                        </name>
                        <name>
                           <span tagx="surname">Coombes</span>
                           <span tagx="given-names">R. C.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Endocrine-responsive breast cancer and strategies for combating resistance</span>
                     <span tagx="source">
                        <i>Nature Reviews Cancer</i>
                     </span>
                     <span tagx="year">2002</span>
                     <span tagx="volume">2</span>
                     <div tagxxx="issue">2</div>
                     <span tagx="fpage">101</span>
                     <span tagx="lpage">112</span>
                     <span class="pub-id'">[10.1038/nrc721]</span>
                     <span class="pub-id'">[2-s2.0-0036488531]</span>
                     <span class="pub-id'">[12635173]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B36"></a>
                  <label>39</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Osborne</span>
                           <span tagx="given-names">C. K.</span>
                        </name>
                        <name>
                           <span tagx="surname">Schiff</span>
                           <span tagx="given-names">R.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Mechanisms of endocrine resistance in breast cancer</span>
                     <span tagx="source">
                        <i>Annual Review of Medicine</i>
                     </span>
                     <span tagx="year">2011</span>
                     <span tagx="volume">62</span>
                     <span tagx="fpage">233</span>
                     <span tagx="lpage">247</span>
                     <span class="pub-id'">[10.1146/annurev-med-070909-182917]</span>
                     <span class="pub-id'">[2-s2.0-79551576468]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B10"></a>
                  <label>40</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Dittmer</span>
                           <span tagx="given-names">J.</span>
                        </name>
                        <name>
                           <span tagx="surname">Leyh</span>
                           <span tagx="given-names">B.</span>
                        </name>
                     </span>
                     <span tagx="article-title">The impact of tumor stroma on drug response in breast cancer</span>
                     <span tagx="source">
                        <i>Seminars in Cancer Biology</i>
                     </span>
                     <span tagx="year">2014</span>
                     <span tagx="volume">31</span>
                     <span tagx="fpage">3</span>
                     <span tagx="lpage">15</span>
                     <span class="pub-id'">[10.1016/j.semcancer.2014.05.006]</span>
                     <span class="pub-id'">[2-s2.0-84902300081]</span>
                     <span class="pub-id'">[24912116]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B24"></a>
                  <label>41</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Jordan</span>
                           <span tagx="given-names">V. C.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Selective estrogen receptor modulation: concept and consequences in cancer</span>
                     <span tagx="source">
                        <i>Cancer Cell</i>
                     </span>
                     <span tagx="year">2004</span>
                     <span tagx="volume">5</span>
                     <div tagxxx="issue">3</div>
                     <span tagx="fpage">207</span>
                     <span tagx="lpage">213</span>
                     <span class="pub-id'">[10.1016/s1535-6108(04)00059-5]</span>
                     <span class="pub-id'">[2-s2.0-1642544604]</span>
                     <span class="pub-id'">[15050912]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B22"></a>
                  <label>42</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Howell</span>
                           <span tagx="given-names">A.</span>
                        </name>
                        <name>
                           <span tagx="surname">Robertson</span>
                           <span tagx="given-names">J. F. R.</span>
                        </name>
                        <name>
                           <span tagx="surname">Abram</span>
                           <span tagx="given-names">P.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Comparison of fulvestrant versus tamoxifen for the treatment of advanced breast cancer
                        in postmenopausal women previously untreated with endocrine therapy: a multinational,
                        double-blind, randomized trial
                     </span>
                     <span tagx="source">
                        <i>Journal of Clinical Oncology</i>
                     </span>
                     <span tagx="year">2004</span>
                     <span tagx="volume">22</span>
                     <div tagxxx="issue">9</div>
                     <span tagx="fpage">1605</span>
                     <span tagx="lpage">1613</span>
                     <span class="pub-id'">[10.1200/jco.2004.02.112]</span>
                     <span class="pub-id'">[2-s2.0-2442648038]</span>
                     <span class="pub-id'">[15117982]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B34"></a>
                  <label>43</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Miller</span>
                           <span tagx="given-names">W. R.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Aromatase inhibitors: mechanism of action and role in the treatment of breast cancer</span>
                     <span tagx="source">
                        <i>Seminars in Oncology</i>
                     </span>
                     <span tagx="year">2003</span>
                     <span tagx="volume">30</span>
                     <div tagxxx="issue">4</div>
                     <span tagx="fpage">3</span>
                     <span tagx="lpage">11</span>
                     <span class="pub-id'">[2-s2.0-0141762745]</span>
                     <span class="pub-id'">[14513432]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B3"></a>
                  <label>44</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Carlson</span>
                           <span tagx="given-names">R. W.</span>
                        </name>
                     </span>
                     <span tagx="article-title">The history and mechanism of action of fulvestrant</span>
                     <span tagx="source">
                        <i>Clinical Breast Cancer</i>
                     </span>
                     <span tagx="year">2005</span>
                     <span tagx="volume">6</span>
                     <div tagxxx="issue">supplement 1</div>
                     <span tagx="fpage">S5</span>
                     <span tagx="lpage">S8</span>
                     <span class="pub-id'">[10.3816/cbc.2005.s.008]</span>
                     <span class="pub-id'">[2-s2.0-21744453325]</span>
                     <span class="pub-id'">[15865849]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B48"></a>
                  <label>45</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Robinson</span>
                           <span tagx="given-names">D. R.</span>
                        </name>
                        <name>
                           <span tagx="surname">Wu</span>
                           <span tagx="given-names">Y.-M.</span>
                        </name>
                        <name>
                           <span tagx="surname">Vats</span>
                           <span tagx="given-names">P.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Activating ESR1 mutations in hormone-resistant metastatic breast cancer</span>
                     <span tagx="source">
                        <i>Nature Genetics</i>
                     </span>
                     <span tagx="year">2013</span>
                     <span tagx="volume">45</span>
                     <div tagxxx="issue">12</div>
                     <span tagx="fpage">1446</span>
                     <span tagx="lpage">1451</span>
                     <span class="pub-id'">[10.1038/ng.2823]</span>
                     <span class="pub-id'">[2-s2.0-84888381937]</span>
                     <span class="pub-id'">[24185510]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B55"></a>
                  <label>46</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Toy</span>
                           <span tagx="given-names">W.</span>
                        </name>
                        <name>
                           <span tagx="surname">Shen</span>
                           <span tagx="given-names">Y.</span>
                        </name>
                        <name>
                           <span tagx="surname">Won</span>
                           <span tagx="given-names">H.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">ESR1 ligand-binding domain mutations in hormone-resistant breast cancer</span>
                     <span tagx="source">
                        <i>Nature Genetics</i>
                     </span>
                     <span tagx="year">2013</span>
                     <span tagx="volume">45</span>
                     <div tagxxx="issue">12</div>
                     <span tagx="fpage">1439</span>
                     <span tagx="lpage">1445</span>
                     <span class="pub-id'">[10.1038/ng.2822]</span>
                     <span class="pub-id'">[2-s2.0-84888391516]</span>
                     <span class="pub-id'">[24185512]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B15"></a>
                  <label>47</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Gee</span>
                           <span tagx="given-names">J. M.</span>
                        </name>
                        <name>
                           <span tagx="surname">Robertson</span>
                           <span tagx="given-names">J. F.</span>
                        </name>
                        <name>
                           <span tagx="surname">Gutteridge</span>
                           <span tagx="given-names">E.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling
                        and oestrogen receptor activity in clinical breast cancer
                     </span>
                     <span tagx="source">
                        <i>Endocrine-Related Cancer</i>
                     </span>
                     <span tagx="year">2005</span>
                     <span tagx="volume">12</span>
                     <div tagxxx="issue">supplement 1</div>
                     <span tagx="fpage">S99</span>
                     <span tagx="lpage">S111</span>
                     <span class="pub-id'">[10.1677/erc.1.01005]</span>
                     <span class="pub-id'">[2-s2.0-25844468319]</span>
                     <span class="pub-id'">[16113104]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B1"></a>
                  <label>48</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Al-Hajj</span>
                           <span tagx="given-names">M.</span>
                        </name>
                        <name>
                           <span tagx="surname">Wicha</span>
                           <span tagx="given-names">M. S.</span>
                        </name>
                        <name>
                           <span tagx="surname">Benito-Hernandez</span>
                           <span tagx="given-names">A.</span>
                        </name>
                        <name>
                           <span tagx="surname">Morrison</span>
                           <span tagx="given-names">S. J.</span>
                        </name>
                        <name>
                           <span tagx="surname">Clarke</span>
                           <span tagx="given-names">M. F.</span>
                        </name>
                     </span>
                     <span tagx="article-title">Prospective identification of tumorigenic breast cancer cells</span>
                     <span tagx="source">
                        <i>Proceedings of the National Academy of Sciences of the United States of America</i>
                     </span>
                     <span tagx="year">2003</span>
                     <span tagx="volume">100</span>
                     <div tagxxx="issue">7</div>
                     <span tagx="fpage">3983</span>
                     <span tagx="lpage">3988</span>
                     <span class="pub-id'">[10.1073/pnas.0530291100]</span>
                     <span class="pub-id'">[2-s2.0-0037388204]</span>
                     <span class="pub-id'">[12629218]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B16"></a>
                  <label>49</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Ginestier</span>
                           <span tagx="given-names">C.</span>
                        </name>
                        <name>
                           <span tagx="surname">Hur</span>
                           <span tagx="given-names">M. H.</span>
                        </name>
                        <name>
                           <span tagx="surname">Charafe-Jauffret</span>
                           <span tagx="given-names">E.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor
                        of poor clinical outcome
                     </span>
                     <span tagx="source">
                        <i>Cell Stem Cell</i>
                     </span>
                     <span tagx="year">2007</span>
                     <span tagx="volume">1</span>
                     <div tagxxx="issue">5</div>
                     <span tagx="fpage">555</span>
                     <span tagx="lpage">567</span>
                     <span class="pub-id'">[10.1016/j.stem.2007.08.014]</span>
                     <span class="pub-id'">[2-s2.0-35848955428]</span>
                     <span class="pub-id'">[18371393]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B29"></a>
                  <label>50</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Li</span>
                           <span tagx="given-names">X.</span>
                        </name>
                        <name>
                           <span tagx="surname">Lewis</span>
                           <span tagx="given-names">M. T.</span>
                        </name>
                        <name>
                           <span tagx="surname">Huang</span>
                           <span tagx="given-names">J.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy</span>
                     <span tagx="source">
                        <i>Journal of the National Cancer Institute</i>
                     </span>
                     <span tagx="year">2008</span>
                     <span tagx="volume">100</span>
                     <div tagxxx="issue">9</div>
                     <span tagx="fpage">672</span>
                     <span tagx="lpage">679</span>
                     <span class="pub-id'">[10.1093/jnci/djn123]</span>
                     <span class="pub-id'">[2-s2.0-44049100934]</span>
                     <span class="pub-id'">[18445819]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B9"></a>
                  <label>51</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Diehn</span>
                           <span tagx="given-names">M.</span>
                        </name>
                        <name>
                           <span tagx="surname">Cho</span>
                           <span tagx="given-names">R. W.</span>
                        </name>
                        <name>
                           <span tagx="surname">Lobo</span>
                           <span tagx="given-names">N. A.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Association of reactive oxygen species levels and radioresistance in cancer stem cells</span>
                     <span tagx="source">
                        <i>Nature</i>
                     </span>
                     <span tagx="year">2009</span>
                     <span tagx="volume">458</span>
                     <div tagxxx="issue">7239</div>
                     <span tagx="fpage">780</span>
                     <span tagx="lpage">783</span>
                     <span class="pub-id'">[10.1038/nature07733]</span>
                     <span class="pub-id'">[2-s2.0-64749093574]</span>
                     <span class="pub-id'">[19194462]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B51"></a>
                  <label>52</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Simões</span>
                           <span tagx="given-names">B. M.</span>
                        </name>
                        <name>
                           <span tagx="surname">Alferez</span>
                           <span tagx="given-names">D. G.</span>
                        </name>
                        <name>
                           <span tagx="surname">Howell</span>
                           <span tagx="given-names">S. J.</span>
                        </name>
                        <name>
                           <span tagx="surname">Clarke</span>
                           <span tagx="given-names">R. B.</span>
                        </name>
                     </span>
                     <span tagx="article-title">The role of steroid hormones in breast cancer stem cells</span>
                     <span tagx="source">
                        <i>Endocrine-Related Cancer</i>
                     </span>
                     <span tagx="year">2015</span>
                     <span tagx="volume">22</span>
                     <div tagxxx="issue">6</div>
                     <span tagx="fpage">T177</span>
                     <span tagx="lpage">T186</span>
                     <span class="pub-id'">[10.1530/ERC-15-0350]</span>
                     <span class="pub-id'">[26381288]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B5"></a>
                  <label>53</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Creighton</span>
                           <span tagx="given-names">C. J.</span>
                        </name>
                        <name>
                           <span tagx="surname">Li</span>
                           <span tagx="given-names">X.</span>
                        </name>
                        <name>
                           <span tagx="surname">Landis</span>
                           <span tagx="given-names">M.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Residual breast cancers after conventional therapy display mesenchymal as well as
                        tumor-initiating features
                     </span>
                     <span tagx="source">
                        <i>Proceedings of the National Academy of Sciences of the United States of America</i>
                     </span>
                     <span tagx="year">2009</span>
                     <span tagx="volume">106</span>
                     <div tagxxx="issue">33</div>
                     <span tagx="fpage">13820</span>
                     <span tagx="lpage">13825</span>
                     <span class="pub-id'">[10.1073/pnas.0905718106]</span>
                     <span class="pub-id'">[2-s2.0-69549131213]</span>
                     <span class="pub-id'">[19666588]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B53"></a>
                  <label>54</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Simões</span>
                           <span tagx="given-names">B. M.</span>
                        </name>
                        <name>
                           <span tagx="surname">Piva</span>
                           <span tagx="given-names">M.</span>
                        </name>
                        <name>
                           <span tagx="surname">Iriondo</span>
                           <span tagx="given-names">O.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Effects of estrogen on the proportion of stem cells in the breast</span>
                     <span tagx="source">
                        <i>Breast Cancer Research and Treatment</i>
                     </span>
                     <span tagx="year">2011</span>
                     <span tagx="volume">129</span>
                     <div tagxxx="issue">1</div>
                     <span tagx="fpage">23</span>
                     <span tagx="lpage">35</span>
                     <span class="pub-id'">[10.1007/s10549-010-1169-4]</span>
                     <span class="pub-id'">[2-s2.0-79960844882]</span>
                     <span class="pub-id'">[20859678]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B41"></a>
                  <label>55</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Piva</span>
                           <span tagx="given-names">M.</span>
                        </name>
                        <name>
                           <span tagx="surname">Domenici</span>
                           <span tagx="given-names">G.</span>
                        </name>
                        <name>
                           <span tagx="surname">Iriondo</span>
                           <span tagx="given-names">O.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Sox2 promotes tamoxifen resistance in breast cancer cells</span>
                     <span tagx="source">
                        <i>EMBO Molecular Medicine</i>
                     </span>
                     <span tagx="year">2014</span>
                     <span tagx="volume">6</span>
                     <div tagxxx="issue">1</div>
                     <span tagx="fpage">66</span>
                     <span tagx="lpage">79</span>
                     <span class="pub-id'">[10.1002/emmm.201303411]</span>
                     <span class="pub-id'">[2-s2.0-84891904837]</span>
                     <span class="pub-id'">[24178749]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B52"></a>
                  <label>56</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Simões</span>
                           <span tagx="given-names">B.</span>
                        </name>
                        <name>
                           <span tagx="surname">O’Brien</span>
                           <span tagx="given-names">C.</span>
                        </name>
                        <name>
                           <span tagx="surname">Eyre</span>
                           <span tagx="given-names">R.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Anti-estrogen resistance in human breast tumors is driven by JAG1-NOTCH4-dependent
                        cancer stem cell activity
                     </span>
                     <span tagx="source">
                        <i>Cell Reports</i>
                     </span>
                     <span tagx="year">2015</span>
                     <span tagx="volume">12</span>
                     <div tagxxx="issue">12</div>
                     <span tagx="fpage">1968</span>
                     <span tagx="lpage">1977</span>
                     <span class="pub-id'">[10.1016/j.celrep.2015.08.050]</span>
                     <span class="pub-id'">[26387946]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B32"></a>
                  <label>57</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Magnifico</span>
                           <span tagx="given-names">A.</span>
                        </name>
                        <name>
                           <span tagx="surname">Albano</span>
                           <span tagx="given-names">L.</span>
                        </name>
                        <name>
                           <span tagx="surname">Campaner</span>
                           <span tagx="given-names">S.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Tumor-initiating cells of HER2-positive carcinoma cell lines express the highest oncoprotein
                        levels and are sensitive to trastuzumab
                     </span>
                     <span tagx="source">
                        <i>Clinical Cancer Research</i>
                     </span>
                     <span tagx="year">2009</span>
                     <span tagx="volume">15</span>
                     <div tagxxx="issue">6</div>
                     <span tagx="fpage">2010</span>
                     <span tagx="lpage">2021</span>
                     <span class="pub-id'">[10.1158/1078-0432.ccr-08-1327]</span>
                     <span class="pub-id'">[2-s2.0-62549096930]</span>
                     <span class="pub-id'">[19276287]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B31"></a>
                  <label>58</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Magnani</span>
                           <span tagx="given-names">L.</span>
                        </name>
                        <name>
                           <span tagx="surname">Stoeck</span>
                           <span tagx="given-names">A.</span>
                        </name>
                        <name>
                           <span tagx="surname">Zhang</span>
                           <span tagx="given-names">X.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Genome-wide reprogramming of the chromatin landscape underlies endocrine therapy resistance
                        in breast cancer
                     </span>
                     <span tagx="source">
                        <i>Proceedings of the National Academy of Sciences of the United States of America</i>
                     </span>
                     <span tagx="year">2013</span>
                     <span tagx="volume">110</span>
                     <div tagxxx="issue">16</div>
                     <span tagx="fpage">E1490</span>
                     <span tagx="lpage">E1499</span>
                     <span class="pub-id'">[10.1073/pnas.1219992110]</span>
                     <span class="pub-id'">[2-s2.0-84876204394]</span>
                     <span class="pub-id'">[23576735]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B58"></a>
                  <label>59</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Yun</span>
                           <span tagx="given-names">J.</span>
                        </name>
                        <name>
                           <span tagx="surname">Pannuti</span>
                           <span tagx="given-names">A.</span>
                        </name>
                        <name>
                           <span tagx="surname">Espinoza</span>
                           <span tagx="given-names">I.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Crosstalk between PKC
                        <i>α</i> and Notch-4 in endocrine-resistant breast cancer cells
                     </span>
                     <span tagx="source">
                        <i>Oncogenesis</i>
                     </span>
                     <span tagx="year">2013</span>
                     <span tagx="volume">2, article e60</span>
                     <span class="pub-id'">[10.1038/oncsis.2013.26]</span>
                     <span class="pub-id'">[2-s2.0-84881405994]</span>
                  </span>
               </li>
               <li tag="ref">
                  <a name="B42"></a>
                  <label>60</label>
                  <span class="element-citation'">
                     <span class="person-group'">
                        <name>
                           <span tagx="surname">Ramaswamy</span>
                           <span tagx="given-names">B.</span>
                        </name>
                        <name>
                           <span tagx="surname">Lu</span>
                           <span tagx="given-names">Y.</span>
                        </name>
                        <name>
                           <span tagx="surname">Teng</span>
                           <span tagx="given-names">K.-Y.</span>
                        </name>
                        <etal></etal>
                     </span>
                     <span tagx="article-title">Hedgehog signaling is a novel therapeutic target in tamoxifen-resistant breast cancer
                        aberrantly activated by PI3K/AKT pathway
                     </span>
                     <span tagx="source">
                        <i>Cancer Research</i>
                     </span>
                     <span tagx="year">2012</span>
                     <span tagx="volume">72</span>
                     <div tagxxx="issue">19</div>
                     <span tagx="fpage">5048</span>
                     <span tagx="lpage">5059</span>
                     <span class="pub-id'">[10.1158/0008-5472.CAN-12-1248]</span>
                     <span class="pub-id'">[2-s2.0-84867116494]</span>
                     <span class="pub-id'">[22875023]</span>
                  </span>
               </li>
            </ul>
         </div>
      </back>
      <div tagxxx="floats-group">
         <fig>
            <label>Figure 1</label>
            <caption>
               <p>Basics of Notch signalling pathway. Notch signalling activation occurs via an interaction
                  between DSL ligand and Notch receptor on adjacent cells. This interaction leads to
                  force being applied to the extracellular domain of Notch, as DSL ligand undergoes
                  endocytosis into the signalling cell, leading to a conformational change within the
                  negative regulatory region (NRR). This conformational change exposes a cleavage site
                  (S2) for the ADAM10 and ADAM17 proteases. The extracellularly truncated Notch protein
                  then undergoes cleavage at site 3 (S3), mediated by 
                  <i>γ</i>-secretase, which releases the Notch intracellular domain (NICD). Finally, NICD translocates
                  into the nucleus and interacts with the DNA binding protein RBPj and the transcriptional
                  coactivators MAML and p300 to initiate transcription of downstream targets including
                  the
                  <i> Hes</i> and
                  <i> Hey</i> family of genes.
               </p>
            </caption>
            <graphic></graphic>
         </fig>
      </div>
   </article>
</html>